Blog

Press

Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas

Quick Take: The clinics will open in Austin and Bee Cave, Texas, and will be led by Illumma KetamineOne Capital Limited (NEO: MEDI) (OTC: KONEF), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has recently entered into a non-binding letter of intent (“LOI”) to enter into an arranged partnership (“Arrangement”) with Illumma LLC, (“Illumma”). With clinics located in Austin and Bee Cave, Texas, Illumma is a leading ketamine infusion practice treating individuals with mental health issues, mood disorders and chronic pain issues. Under the contemplated Arrangement, Illumma’s two locations would…

Press

Journey Colab secures $12M Series A funding for Phase 1 trial of Mescaline HCl, JOUR-001, for treatment of Alcohol Use Disorder

Quick Take: Journey Colab has raised $12M in equity to fund the development of synthetically-derived psychedelic products These products are aimed at treating alcohol addiction, among other mental health disorders. Journey Colab Corp., a privately-held psychedelic pharmaceutical startup initially funded by Sam Altman and Apollo Projects, has raised $12M in new equity funding to develop synthetically-derived and patent-protected psychedelic products to treat addiction and other mental health disorders. Series A investors include MBX Capital, a leading healthcare and biotechnology venture fund; Delphi VC; Uprising; Lionheart Ventures; Sam Altman and Apollo Projects; and Drew Houston (co-founder and CEO of Dropbox). “We’re…

Field Trip Health Ltd.

Press

Field Trip Health opens Europe’s first psychedelic therapy healthcare facility

Quick Take: The facility will offer a team of psychiatrists and nurses to help guide patients in psychedelic therapy. Field Trip Health (TSX: FTRP), the world’s first facility for psychedelic-assisted psychotherapy, is thrilled to announce the opening of its new branch in Amsterdam. At Field Trip, a dedicated team of professionals, including psychiatrists, and nurses, guide people in therapy supported by truffle-induced trips. The publicly traded North American company combines current scientific insights with caring counseling focusing on safety, connection, and compassion. Piet Heinkade in Amsterdam is its sixth facility and first outside the U.S. and Canada. Self-discovery and inner healing Therapy using truffles can…

Filament Health

Press

Filament Health Shares to Commence Trading on the OTC Market

Quick Take: Filament has recieved approval from the Financial Regulatory Authority that it is qualified to begin trading on the OTC Pink Market. Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on the OTC Pink Market (the “OTC”) in the United States under the symbol “FLHLF”. The Company has also submitted an application for uplisting shares to the OTCQB® Venture Market (“OTCQB”). Filament also applied to the Depository Trust Company (“DTC”) for DTC eligibility, which would greatly simplify the process of trading…

Mindcure

Press

MINDCURE Announces Financial Results for Fiscal 2021

VANCOUVER, BC, August 31, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research in psychedelics, today announced its financial results for the three and twelve months ended May 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated.   Business Highlights Commenced the development of iSTRYM, the Company’s digital therapeutics tool, a first-of-its-kind software application that will optimize the healing journey for both patients and clinicians — before, during, and after therapy sessions; Submitted a provisional patent application with the United States Patent and…